Sanofi raises outlook as specialty care, vaccines lift sales

The French drugmaker said it now expected earnings per share to increase 7%-8% this year, up from 6%-7% previously.

PARIS: Sanofi raised its 2020 earnings guidance for the second time this year after posting slightly stronger-than-expected third-quarter results, helped by growth at its specialty care and vaccines units.

The French drugmaker said it now expected earnings per share to increase 7%-8% this year, up from 6%-7% previously.